Company profile: EpiEP
1.1 - Company Overview
Company description
- Provider of pressure-guided access solutions for epicardial procedures, featuring the EpiAccess System for real-time guidance to the pericardial space via a needle with a fiber optic pressure sensor; the single-use EpiAccess Needle for precise tip location with real-time pressure data; and a compact Control Unit that captures and displays pressure data.
Products and services
- Control Unit: A compact, medical-grade device that captures and displays real-time pressure data from the EpiAccess Needle, aiding the guidance of epicardial procedures
- EpiAccess™ Needle: A single-use needle with a fiber optic pressure sensor at the tip, delivering real-time pressure data for precise needle tip localization during epicardial access
- EpiAccess™ System: An integrated medical device enabling pressure-guided access to the pericardial space, using a needle with a fiber optic pressure sensor for real-time guidance during epicardial procedures
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to EpiEP
Tissium
HQ: France
Website
- Description: Provider of synthetic, biodegradable, light-activated sealants, surgical adhesives, and biomaterial solutions for wound closure and tissue reconstruction, with a focus on minimally invasive surgery. Offerings include SETALIUM Vascular Sealant, ECLIPSIUM laparoscopic hernia repair system, biomorphic programmable polymers, IBD fistula-healing solutions, and COAPTIUM Connect for sutureless nerve repair.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tissium company profile →
Amarin
HQ: Ireland
Website
- Description: Provider of prescription cardiovascular therapy and clinical research, including VASCEPA/VAZKEPA (icosapent ethyl) to reduce cardiovascular risk in patients with elevated triglycerides and established cardiovascular disease, and the REDUCE-IT global outcomes study evaluating VASCEPA in patients with controlled LDL-C and elevated triglycerides to reduce cardiovascular events.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amarin company profile →
Ablacon
HQ: United States
Website
- Description: Provider of AI-guided atrial fibrillation therapies, including the Ablamap System to localize and characterize functional mechanisms of AF for customized ablation; the Ablacath Mapping Catheter, used with Ablamap to identify and ablate sources outside the pulmonary veins; and the EGF Mapping System using electrographic flow mapping to detect and quantify patterns of electrical wavefront propagation in the atria.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ablacon company profile →
PerSys Medical
HQ: United States
Website
- Description: Provider of specialized medical and emergency products for military, law enforcement, homeland security, and EMS agencies, including the SWAT-T tourniquet, Russell Chest Seal, Celox Rapid B-CON hemostatic device, Warrior Blood & Fluid Warmer Set, Bleed Control Kit, and TruBODIES reanimated tissue training system.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PerSys Medical company profile →
Nectero Medical
HQ: United States
Website
- Description: Provider of a minimally invasive treatment to stabilize growth and prevent rupture of small to mid-sized abdominal aortic aneurysms through the Nectero EAST® System, which uses a dual-balloon catheter to deliver a stabilizer mixture to strengthen the aortic wall; includes the stAAAble Trial to evaluate safety and efficacy in patients with infrarenal abdominal aortic aneurysms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nectero Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for EpiEP
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to EpiEP
2.2 - Growth funds investing in similar companies to EpiEP
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for EpiEP
4.2 - Public trading comparable groups for EpiEP
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →